USB
53
3
LEN
55
6
AA
63
7
CVS
44
-4
FSLR
41
-5
CB
50
4
PGR
64
2
LH
50
2
XYL
41
4
SE
50
-5
FOXA
66
2
GME
65
6
PM
56
6
CAT
62
-4
HPE
70
17
AKAM
40
-22
MOS
46
-3
TAP
58
-2
NDAQ
63
4
TJX
62
3
USB
53
3
LEN
55
6
AA
63
7
CVS
44
-4
FSLR
41
-5
CB
50
4
PGR
64
2
LH
50
2
XYL
41
4
SE
50
-5
FOXA
66
2
GME
65
6
PM
56
6
CAT
62
-4
HPE
70
17
AKAM
40
-22
MOS
46
-3
TAP
58
-2
NDAQ
63
4
TJX
62
3
Financhill
Back

Emergent BioSolutions Quote, Financials, Valuation and Earnings

Write This Down: Tuesday at 2 p.m. ET!

Don't Miss Our LIVE Trade
Buy
72

EBS
Emergent BioSolutions

Last Price:
11.78
Seasonality Move:
5.89%

7 Day Trial

ALL ACCESS PASS

$ 7

Yours Free! Top SIX AI Dividend Stocks Right Now

NO CREDIT CARD REQUIRED!

Emergent BioSolutions Price Quote

$11.78
+0.01 (+7.09%)
(Updated: November 9, 2024 at 5:23 AM ET)

Emergent BioSolutions Key Stats

Buy
72
Emergent BioSolutions (EBS) is a Buy
Day range:
$10.70 - $12.07
52-week range:
$1.42 - $15.10
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.57
P/B ratio:
1.61%
Volume:
2.2M
Avg. volume:
1.5M
1-year change:
432.58%
Market cap:
$622.7M
Revenue:
$1B
EPS:
$-11.24

How Much Does Emergent BioSolutions Make?

Is Emergent BioSolutions Growing As A Company?

  • What Is Emergent BioSolutions's Growth Rate Quarterly?
    Quarterly YoY revenue growth is -0.25%
  • What Is Emergent BioSolutions's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Emergent BioSolutions Stock Price Performance

What Is Emergent BioSolutions 52-Week High & Low?

Emergent BioSolutions Price To Free Cash Flow

Is It Risky To Buy Emergent BioSolutions?

Is Emergent BioSolutions Cash Flow Positive?

  • What Is EBS Cash Flow From Operations?
    Cash flow from operations (TTM) is $77M
  • What Is Emergent BioSolutions’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$48.5M
  • What Is Emergent BioSolutions’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$45.7M

Emergent BioSolutions Return On Invested Capital

  • Is Management Doing A Good Job?
    EBS return on invested capital is -37.89%
  • What Is Emergent BioSolutions Return On Assets?
    ROA measures how assets are converting to revenues and is -31.86%
  • What Is EBS Return On Equity?
    ROE is a measure of profitability and is -87.53%

Emergent BioSolutions Earnings Date & Stock Price

Emergent BioSolutions Competitors

Emergent BioSolutions Dividend Yield

Emergent BioSolutions Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 874.53%
Revenue: -25.11% -1.24%

Analyst Recommendations

Buy Recommendations: 1
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 12.00
Upside from Last Price: 1.95%

Major Shareholders

  • How many EBS shares are owned by institutional investors?
    42.8M EBS shares are owned by institutional investors
  • How many EBS shares are owned by insiders?
    3.9M EBS shares are owned by insiders